Artiva Biotherapeutics (NASDAQ: ARTV) Soars on Positive Clinical Data, FDA Alignment, and Analyst Price Target Hike
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameArtiva Biotherapeutics Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









